$-0.06
(Market cap
$4 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
2.3
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-9.7 %
-
ROCE
-- %
-
Industry P/E
51.41
-
EV/EBITDA
0.4
-
Debt to Equity
0
-
Book Value
$14.6
-
EPS
$-50.3
-
Face value
--
-
Shares outstanding
2,518,590
6 Years Aggregate
CFO
$-27.94 Mln
EBITDA
$-32.57 Mln
Net Profit
$-46.99 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
iSpecimen Inc (ISPC)
| -85.2 | -23.4 | -54.0 | -94.8 | -87.7 | -80.0 | -- |
|
BSE Sensex
| -8.8 | 0.6 | 1.8 | -4.4 | 6.0 | 6.6 | 10.8 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
|---|---|---|---|---|
|
iSpecimen Inc (ISPC)
| -90.2 | -73.2 | -63.6 | -82.4 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
iSpecimen Inc (ISPC)
|
1.5 | 3.9 | 0.5 | -11.4 | -1,376.3 | -473.4 | -- | 2.3 |
| 234.5 | 8,304.9 | 1,040.9 | 157.5 | 17.9 | 29.5 | 53.5 | 15.6 | |
| 5.8 | 11,684.2 | 5.0 | -900.0 | -17,920.0 | -44 | -- | 5.8 | |
| 24.6 | 7,330.9 | 825.7 | -48.1 | -0.5 | -2.3 | -- | 3.6 | |
| 35.7 | 7,762.7 | 2,531.6 | 442.8 | 27.9 | -- | 19.8 | 29.8 | |
| 44.9 | 7,578.5 | 1,004.9 | -25.1 | -1.8 | -2.3 | -- | 7.7 | |
| 96.4 | 7,971.3 | 1,362.1 | 236.5 | 24.8 | 11.5 | 34.8 | 3.9 | |
| 19.8 | 11,247.2 | 1,121.1 | -157.4 | -17.8 | -2.3 | -- | 1.7 | |
| 21.5 | 7,178.3 | 1,048.9 | -318.7 | -27.7 | -21.3 | -- | 5.1 | |
| 18.2 | 8,248.5 | 1,672.3 | 327.4 | 8.3 | 17.1 | 26.5 | 4.3 |
Shareholding Pattern
View DetailsAbout iSpecimen Inc (ISPC)
iSpecimen Inc. operates marketplace that provides biospecimens to life science researchers in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It develops and operates iSpecimen Marketplace, a proprietary online marketplace... platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. The company's marketplace offers human biospecimens, including biofluids, such as whole blood, plasma, serum, urine, saliva, sputum, nasopharyngeal material, and cerebral spinal fluid; solid tissue comprising fresh, fixed, and cryopreserved tissue, as well as formalin-fixed paraffin embedded blocks, slides, and curls; and hematopoietic stem and immune cells, including bone marrow, cord blood, whole blood, or sub-components of these tissues, such as peripheral blood mononuclear cells and other isolated cell types. It serves biopharmaceutical companies, in vitro diagnostic companies, and government/academic institutions. iSpecimen Inc. was incorporated in 2009 and is headquartered in Woburn, Massachusetts. Read more
-
CEO, CFO, Treasurer & Director
Ms. Tracy Wilson Curley
-
Senior Vice President of Operations
Ms. Leslie Hoyt
-
Headquarters
Woburn, MA
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for iSpecimen Inc (ISPC)
What is the current share price of iSpecimen Inc (ISPC) Today?
The share price of iSpecimen Inc (ISPC) is $1.54 (NASDAQ) as of 28-Aug-2026 16:00 EDT. iSpecimen Inc (ISPC) has given a return of -87.68% in the last 3 years.
What is the current PB & PE ratio of iSpecimen Inc (ISPC)?
Since, TTM earnings of iSpecimen Inc (ISPC) is negative, P/E ratio is not available.
The P/B ratio of iSpecimen Inc (ISPC) is 2.32 times as on 28-Aug-2026, a 70 discount to its peers’ median range of 7.80 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
-0.01 |
0.02 |
2024 |
-0.01 |
0.03 |
2023 |
0.00 |
0.00 |
2022 |
0.00 |
0.00 |
2021 |
-0.01 |
0.00 |
What is the 52 Week High and Low of iSpecimen Inc (ISPC)?
The 52-week high and low of iSpecimen Inc (ISPC) are Rs 127.20 and Rs 1.40 as of 30-Aug-2026.
What is the market cap of iSpecimen Inc (ISPC)?
iSpecimen Inc (ISPC) has a market capitalisation of $ 4 Mln as on 28-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in iSpecimen Inc (ISPC)?
Before investing in iSpecimen Inc (ISPC), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.